CCND1 and glioblastoma: Glioblastoma cells treated with a combination of EPZ015666 and PP242 resulted in a significant loss of cell viability, an increase in the number of apoptotic cells and a reduction in the expression of c-MYC and cyclin D1 (Holmes et al., 2019).